Kim, J., Lee, J., Yoon, D., Son, M., Kim, M., Ha, S., . . . Chung, K. W. (2023, October). Thiobarbiturate-Derived Compound MHY1025 Alleviates Renal Fibrosis by Modulating Oxidative Stress, Epithelial Inflammation, and Fibroblast Activation. Antioxidants.
Chicago Style (17th ed.) CitationKim, Jeongwon, et al. "Thiobarbiturate-Derived Compound MHY1025 Alleviates Renal Fibrosis by Modulating Oxidative Stress, Epithelial Inflammation, and Fibroblast Activation." Antioxidants Oct. 2023.
MLA (9th ed.) CitationKim, Jeongwon, et al. "Thiobarbiturate-Derived Compound MHY1025 Alleviates Renal Fibrosis by Modulating Oxidative Stress, Epithelial Inflammation, and Fibroblast Activation." Antioxidants, Oct. 2023.
Warning: These citations may not always be 100% accurate.